Abstract
An 80-year-old man with no complaint was referred to our department because of high serum CEA level. He was diagnosed as non-small cell lung cancer (adenocarcinoma) of the left lower lobe (c-T2aN0M0, stage IB), and therefore the left lower lobectomy with lymph node dissection was performed. Pathological staging was p-T2aN1 (#10) M0, stage IIA, and EGFR mutation was negative. Adjuvant chemotherapy with UFT was started, but multiple hilar and mediastinal lymph nodes metastases soon appeared. Carboplatin (CBDCA)+paclitaxel (PTX), erlotinib, and docetaxel (DOC) were attempted after that, but the lymph nodes increased in size and the CEA level was up to 159.8 ng/mL. At about the same time, brain and pulmonary metastases were recognized. After radiation for the chest lymph nodes and stereotactic radiosurgery (SRS) for the brain metastasis, oral S-1 monotherapy was introduced. Soon after, the lymph nodes shrinked and the CEA level decreased. Also, the pulmonary metastasis disappeared. Although a right supraclavicular lymph node metastasis was resected during the clinical course, the S-1 monotherapy has been continued with no serious adverse event. He is well (PS 0) without recurrent lesion, and his serum CEA level is within the normal limit.
| Original language | English |
|---|---|
| Pages (from-to) | 1201-1203 |
| Number of pages | 3 |
| Journal | Japanese Journal of Cancer and Chemotherapy |
| Volume | 40 |
| Issue number | 9 |
| Publication status | Published - 2013 Sept |
| Externally published | Yes |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Chemotherapy
- Non-small cell lung cancer (NSCLC)
- S-1
ASJC Scopus subject areas
- General Medicine
Fingerprint
Dive into the research topics of 'A case of recurrent non-small cell lung cancer successfully treated with multiple modality therapies including S-1 monotherapy as fifth-line chemotherapy'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS